Inhibition, by aspirin, of platelet aggregation, prostaglandin synthes
is, smooth muscle cell proliferation, and thromboxane genesis has pote
ntial therapeutic uses in renal diseases, Clinically, some benefit fro
m aspirin has been shown in some forms of glomerulonephritis but not i
n others, such as renovascular hypertension, pregnancy-induced hyperte
nsion, and diabetic nephropathy, Experimentally, aspirin aided in amel
ioration of cyclosporine toxicity and in preservation of explanted kid
neys being prepared for transplantation. (C) 1996 by the National Kidn
ey Foundation, Inc.